AT+ Biomedical

AT+ assists with biomedical testing, clinical diagnosis and provides nutritional, dietary and medical advices, seeking the involvement of the NHS.


In order to ascertain the benefit of the biomedical intervention proposed at ATPlus, we designed an evaluation questionnaire covering a range of possible positive and negative outcomes and characterising the intervention conducted.

A total of 100 families responded to the evaluation questionnaire. Ninety two percent (92%) had followed a biomedical intervention. 33% of these had also followed an ABA programme, and 15% of them a Son-Rise home programme.

Of the families undergoing a biomedical intervention, 90% followed a gluten-free casein-free diet and 58% received methyl-cobalamin (MB12).

The outcome of the intervention was reported for 41% of the families as very good, for 34% as being of moderate benefit, for 11% as being of mixed benefit, and for 14% as having unclear or not benefit (Figure 1). Overall 75% of the families reported a moderate or very good outcome.


Figure 1: Overall benefit of the Biomedical Intervention.

The families who reported a very good overall outcome indicated improvement in all scored areas. The highest were improvements in gut health (68% of the families reported good improvement), and in understanding of language (68% of the families reported good improvement). Whilst all areas were rated as showing good level of improvements for more at least 50% of the families, including socialisation, behaviour and the immune system.